Centro Médico Teknon
| Turchia | Austria | Spanyol | |
| Whipple surgery | da $18,000 | da $45,000 | da $25,000 |
| Uterine Trachelectomy | da $5,500 | da $14,500 | da $10,000 |
| Robotic da Vinci prostatectomy | da $17,000 | da $20,000 | da $10,000 |
| Radiation therapy for colorectal cancer | da $7,000 | da $12,000 | da $10,000 |
| Proton-beam therapy | da $70,000 | da $80,000 | da $26,073 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi dei trattamenti di Adenocarcinoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Adenocarcinoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Adenocarcinoma.
Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.
She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.
Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.
Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.